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Computerised interventions designed to reduce 
potentially inappropriate prescribing in hospitalised 
older adults: a systematic review and meta-analysis 
 
Abstract  
Background: Computerised interventions have been suggested as an effective strategy to reduce 
potentially inappropriate prescribing (PIP) for hospitalised older adults. This systematic review and 
meta-analysis examined the evidence for efficacy of computerised interventions designed to reduce 
PIP in this patient group.  
Methods: An electronic literature search was conducted using 8 databases up to October 2017. 
Included studies were controlled trials of computerised interventions aiming to reduce PIP in 
hospitalised older adults (≥65 years). Risk of bias was assessed using Cochrane’s Effective Practice 
and Organisation of Care criteria.  
Results: Of 653 records identified, eight studies were included - two randomised controlled trials, 
two interrupted time series analysis studies, and four controlled before-after studies. Included 
studies were mostly at a low risk of bias. Overall, seven studies showed either a statistically 
significant reduction in the proportion of patients prescribed a potentially inappropriate medicine 
(PIM) (absolute risk reduction {ARR} 1.3% - 30.1%), or in PIMs ordered (ARR 2% - 5.9%). However, 
there is insufficient evidence thus far to suggest that these interventions can routinely improve 
patient-related outcomes. It was only possible to include three studies in the meta-analysis – which 
demonstrated that intervention patients were less likely to be prescribed a PIM (odds ratio 0.6; 95% 
CI 0.38, 0.93).  No computerised intervention targeting potential prescribing omissions (PPOs) was 
identified. 
Conclusions: This systematic review concludes that computerised interventions are capable of 
statistically significantly reducing PIMs in hospitalised older adults. Future interventions should strive 
to target both PIMs and PPOs, ideally demonstrating both cost-effectiveness data and clinically 














Prescribing medicines for multi-morbid older adults is a challenging process, and thus potentially 
inappropriate prescribing (PIP) remains to be a significant problem in this patient group [1]. Across 
the literature, there appears to be a higher prevalence of PIP amongst hospitalised older adults 
compared to those who are community-dwelling [2-4]; this is often due to medicines reconciliation 
issues at transitions of care, and because acutely ill older adults are usually exposed to new 
medicines under the care of multiple prescribers in hospital [5]. Computerised interventions have 
been suggested as an effective strategy to improve the appropriateness of prescribing for 
hospitalised older adults [4]. In the hospital setting, electronic prescribing and computerised 
physician order entry (CPOE) systems have been shown to reduce prescribing errors, and aid in the 
prevention of adverse drug events (ADEs) [6, 7].  
However, no review has yet summarised the evidence regarding the impact of computerised 
interventions to reduce PIP in older adults specifically in the hospital setting. The primary aim of this 
paper was to collect all currently available evidence of prospective controlled studies that have 
utilised computerised interventions capable of independently identifying PIP, and which aimed to 
improve the appropriateness of prescribing in hospitalised older adults (≥65 years). Secondly, we 
aimed to quantify the effect that these computerised interventions could have on reducing PIP in 
hospitalised older adults by conducting a parallel meta-analysis.  
 
Methods 
This systematic review and meta-analysis was reported in compliance with PRISMA guidelines [8]. 
The inclusion criteria, exclusion criteria, and methods for the analysis were established in advance, 
and documented in a protocol, which was registered with the International Prospective Register of 
Systematic Reviews (PROSPERO): CRD42017059795, which can be accessed from 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42017059795. A comprehensive 
electronic search of the literature was conducted using the following eight databases from inception 
up to and including October 2017: PubMed, EMBASE, Medline (via Ovid), Web of Science, CINAHL, 
Cochrane Central Register of Controlled Trials, PsycInfo, and ClinicalTrials.gov. The search strategy 
was developed in PubMed using a combination of key words and Medical Subject Headings, as 
demonstrated in the Supplementary Data. For each of the remaining databases, the search strategy 
was modified to suit their specific search capabilities if necessary. Additionally, our hand search 
involved scrutinising the bibliographies of (i) any review papers that looked at computerised 
interventions in reducing PIP in older adults across different healthcare settings, and (ii) all papers 
that were included at the full text review stage to ensure no other relevant studies were missed.  
Eligibility criteria 
Studies were eligible if they described a controlled intervention in which an objective was to reduce 
PIP in hospitalised older adults (≥65 years) using computer-generated recommendations. The 
primary outcomes of interest for this review were: reductions in PIP or patients with PIP. The 
secondary outcomes of interest were patient outcomes and acceptance rates of recommendations. 
As determined a priori, studies involving a multi-faceted intervention would be included only if the 
effect of the computerised intervention on reducing PIP could be clearly determined.  No date or 
language restrictions were applied.  
Study selection 
For the first stage of study selection, one reviewer screened titles to eliminate papers that were 
clearly not relevant to the research question. Secondly, two reviewers independently screened titles 
and abstracts to identify potentially pertinent full texts. The last stage involved papers being read in 
full and their suitability for inclusion was determined independently by two reviewers. Two authors 
were contacted to supply any additional information required to decide on inclusion of the full texts 
[9, 10]. Consensus on inclusion was reached by discussion between reviewers, with arbitration by a 
senior supervisor if necessary. 
Data extraction 
Data extraction was performed by one reviewer and verified by another. A data extraction form was 
piloted on two papers and adjusted thereafter where necessary. A list of the data variables extracted 
can be found in the Supplementary Data. All authors of the included papers were contacted to 
provide supplementary information where required. 
Risk of bias assessments 
Two review authors independently assessed risk of bias for the included studies according to 
Cochrane’s Effective Practice and Organisation of Care (EPOC) risk of bias criteria [11]. Consensus on 
the assessments was reached by discussion, with advice from a senior supervisor if required. This 
tool was used to determine if any of the included studies were at a high risk of bias which may 
impact the findings from the narrative summary or meta-analysis. 
Data synthesis 
Quantitative analysis was conducted if at least two studies had a common comparable outcome 
measure, and if pooling their results was deemed appropriate. Study heterogeneity was assessed 
qualitatively by reviewing the differences in the interventions and study design, whereas statistical 
heterogeneity was assessed using the I2 statistic. Review Manager 5.3 was employed to determine 
the pooled estimate of effect and 95% confidence intervals (CIs), with p < 0.05 considered 
statistically significant. When it was not possible to combine outcome data due to the variability in 




A total of 653 studies were identified after duplicates were removed. After the exclusion of records 
based on their titles and abstracts, 20 full texts were assessed for eligibility. Eight papers were 
suitable for inclusion in the systematic review. A PRISMA flow diagram describes the flow of studies 












Figure 1: PRISMA flow diagram of search strategy results. 
Characteristics of included studies 
The included studies’ characteristics and outcomes are provided in Table 1. A more detailed 
summary of each intervention is provided in the Supplementary Data. In four of the studies, the 
intervention utilised clinical decision support within a CPOE system [12-15]. In three other studies, 
the intervention comprised of alerts or reminders embedded into a CPOE system [16-18]. The 
remaining study involved the use of INTERcheck® software, a ‘computerised prescription support 
system’ which aimed to reduce PIMs, potentially severe drug-drug interactions, and anticholinergic 
burden [10]. The medicines on admission were reviewed using the computerised tool and changed 
according to the INTERcheck® indication. This was the only included intervention not carried out at 
the point of PIM prescribing. In total, there were 18,507 control patients and 24,535 intervention 
patients across 6 of the studies [10, 12-14, 16, 18]. One study did not report the total number of 
patients [17], and the remaining study reported patient visits only [15]. 
Six of the eight included studies utilised computerised alerts or reminders incorporated into a CPOE 
system, which appeared in various forms to notify healthcare professionals of PIP instances at the 
time a PIM was ordered [12, 14-18]. While some alerts simply provided information to the 
healthcare professional to guide prescribing [15, 17], other alerts provided recommendations that 
required acceptance or rejection at the time a medication was ordered [12]. Five of the six studies 
that utilised alerts or reminders suggested an alternative to PIM use [12, 14, 15, 17, 18]. The study 
by Lester et al. was the exception to this; they stated that the suggested alternative may also be 
inappropriate for certain older patients, thus forcing the prescriber to think for themselves regarding 
treatment options and the health status of individual patients [16]. 
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orders were discontinued 
in the intervention arm 
(48.9%) vs the control arm 
(31.2%)†.  
 
Not applicable. Control vs Intervention: 
- Mean hospital LOS (6.8 vs 7.7 days)†. 
- % Patient death within 30 days of 
hospitalisation (5.8 vs 6)†. 
- % Patients discharged home (36.9 vs 
43.2)†. 
- % Patients re-admitted within 30 days 
of discharge (16.4 vs 18.6)†. 
- % Patients with ≥ 1 hospital 
complication (44.9 vs 47.2)†. 
Ghibelli  
et al. [10]  
Italy Acute geriatric 
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Between admission and 
discharge, the intervention 
resulted in a reduction in 
patients with PIMs (41.7% 
vs 11.6%)*. 
Between admission and 
discharge, the intervention 
resulted in a reduction in 
the prevalence of PIMs out 
of total medicines (7.6% vs 
1.7%)*. 
 
Not applicable. Not assessed. 
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Not stated. During intervention 
periods, 69% of initial 
orders were not consistent 
with recommendations 
(potentially inappropriate) 
vs 77% during control 
periods*. 
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The rate of ADEs was lower for 
intervention patients compared with 
control patients (3.4% vs 7.1%)*.  
No significant differences were 
observed (intervention vs control) in:  
- % admission rate (53 vs 50)†.  
- reversal drug administration (10 vs 
11)†.  
- number of 10-fold orders (17 vs 21)†. 
- emergency department LOS (5.6 vs 5.8 
days)†. 
Lester    
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Pre-alert vs post-alert: 
patients prescribed 
diphenhydramine (26.9% 
vs 20%)* and 
metoclopramide (16.7% vs 
12.5%)*. There was no 
decrease in patients 
prescribed antipsychotics 
(8.8% vs 9.2%)†. 
Not stated. Not applicable. Not assessed. 
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The authors state “ a 
decline in the number of 
patients exposed to a 
subset of potentially 
problematic medications”. 
Specific figures are not 
reported to reflect this, 
but the authors do state a 
reduction in the number of 
PIMs ordered per patient 
per day (0.07 vs 0.054)*. 
The mean rate of non-
recommended medicines 
(PIMs) ordered decreased 
from 11.56 to 9.94 orders 
per day post- 
intervention*. 
Not applicable. Not assessed. 
Peterson 
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Not stated.  
 
The intervention reduced 
the prescription of non-
recommended drugs 
(10.8% vs 7.6% of total 
orders)*. 
29.3% 
- 29.3% of 
prescriptions for 
psychotropics 
agreed with system 
recommendations. 
Patients in the intervention cohort had 
a lower in-hospital fall rate (0.28 vs 0.64 
falls per 100 patient-days*.  
No difference in LOS was detected 
between control and intervention 
periods, with identical median and 
interquartile range at 4 days and 2 to 6 
days.   
Terrell    
et al. [14]  
USA Emergency 








To evaluate the 
effectiveness of CDS in 
reducing PIP in older 
adults 
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There were significantly 
fewer patients prescribed 
PIMs by the intervention 
physicians compared with 
the control physicians 
(2.6% vs 3.9%)*.  
Lower proportion of 
inappropriate medications 
in the intervention group 
(3.4% vs 5.4%)*.  
 
43% 
- Decision support 
was provided 114 
times to physicians, 
who accepted 49 
(43%) of the 
recommendations. 
Not assessed. 
C: Control, I: Intervention, CDSS: Computerised decision support system, LOS: Length of stay, PIM: Potentially inappropriate medicine, DDI: Drug-drug interaction, CDS: Clinical decision support, 
ADE: Adverse drug event, CPOE: Computerised physician order entry, * Statistically significant difference, † No statistically significant difference. 
 
Results of the risk of bias assessments  
The results of the risk of bias assessments are provided in the Supplementary Data. All of the 
included studies were found to be at a low risk of bias, with one exception where the risk of bias was 
deemed unclear [17]. Both randomised controlled trials (RCTs) recognise that they may have been at 
risk of contamination [12, 14]. However, the potential for contamination in these studies, if present, 
would tend to bias against finding an effect of the intervention.  
According to Cochrane’s EPOC criteria [11], the controlled before-after studies must be deemed 
‘high risk’ with regard to the two selection bias domains. Three of the four controlled before-after 
studies did not provide enough information to confirm that the baseline characteristics and outcome 
measurements are similar [16-18], and thus the risk of bias was deemed ‘unclear’. 
 
Reduction in patients with PIMs 
Quantitative analysis  
Three of the eight studies reported the exact number of patients that were prescribed PIMs as an 
outcome, and so were amenable to quantitative analysis [10, 14, 18]. In these three studies, there 
were a total of 29,791 patients/patient visits (14,860 and 14,931 in the intervention and control 
arms respectively). Given the heterogeneous types of intervention and considerable statistical 
heterogeneity between the study results (I2 = 82%;  p = 0.004), a random-effects model was 
performed to provide a pooled estimate of effect. Our meta-analysis found that patients in the 
intervention group were less likely to be prescribed PIMs post-intervention (odds ratio 0.6, 95% CI: 
0.38, 0.93) (Figure 2). These three studies were found to be at a low risk of bias, so we can be 
reasonably confident in the results of this meta-analysis. 
 
 
Figure 2: Forest plot for the odds ratio for the reduction in the proportion of patients prescribed PIMs post-intervention. 
Narrative summary  
Four of the included studies reported results on the effect the intervention had on the proportion of 
patients prescribed PIMs, all of which showed a statistically significant reduction (p < 0.05) for this 
outcome [10, 14, 16, 18]. Where it was possible to calculate, there was an absolute risk reduction 
(ARR) of 1.3% – 30.1% [10, 14, 18], and a relative risk reduction (RRR) of 16.7% - 72.2% [10, 14, 16, 
18] in patients prescribed PIMs across the studies.  
 
Reduction in PIMs prescribed  
Due to the variability in which the results were reported, a meta-analysis could not be performed for 
this primary outcome. Where it was possible to calculate, there was an ARR of 2% – 5.9% [10, 14, 
15], and a RRR of 14% - 77.6% [10, 14, 15, 17] in PIMs prescribed across the studies. Overall, six 
studies showed a reduction in the number of PIMs prescribed when comparing the intervention and 
control groups, with five studies demonstrating statistically significant reductions (p < 0.01) [12-15, 
17]. The only exception to this was the study by Boustani et al., whereby the intervention group still 
had a greater discontinuation rate in anticholinergic drug (PIM) orders vs the control group (48.9% vs 
31.2%; p = 0.11) [12]. As previously mentioned, contamination may have been an issue in this study 
which may have reduced the difference found between the groups. Given the overall low risk of bias 
in these studies, we can be reasonably confident in the results provided. 
 
Acceptance rates of computerised recommendations 
Four of the included studies have data on acceptance rates or levels of agreement with the 
computer’s recommendations (Table 2) [13-15, 18]. 
 
 
Reasons for not accepting recommendations 
Three studies identified reasons why prescribers did not accept or may have overridden the 
computerised recommendations [13, 14, 17]. A patient having previously tolerated a PIM was the 
most common reason for non-acceptance of recommendations in two of the studies [13, 14], while 
it remained the second most common in the remaining study after the reason that the prescriber 
felt that the regimen was clinically indicated [17]. This perhaps suggests a degree of inertia with 
regard to tackling PIP in the acute hospital setting.  
Some of the other reasons given in these three studies included:  
• On the advice of a consultant, the medicine is not to be changed [13]. 
• No good substitute exists for the medication [14]. 
• The patient insists on the medication [14]. 
• Interaction noted, regimen clinically indicated, will closely monitor [17]. 






% Acceptance Rates or Agreement with Recommendations (intervention arm) 
Rate Details 
Agostini         





95% 95% of patients were successfully directed to a nonpharmacological 
sleep protocol, or to a safer sedative-hypnotic drug.  
Terrell 





9 high-use and high 
impact PIMs 
43% Decision support was provided 114 times to intervention physicians, 
who accepted 49 (43%) of the recommendations.  
Griffey 







31%; 7.5% Of initial medicine orders: 403/1283 (31%) were consistent with the 
computerised recommendations for medication dosage/frequency. 
7.5% of suggestions for alternatives were accepted (4/53).  
Peterson       






selected by expert 
panel 
29.3% 29.3% of prescriptions for psychotropics were in agreement with 
system recommendations. 
Table 2: Studies that assessed acceptance rates of the computerised interventions. 
Clinical Outcomes 
Three of the included studies assessed clinical outcomes [12, 13, 15]. Griffey et al. demonstrated a 
statistically significant reduction in ADEs (3.4% vs 7.1%; p = 0.02) [13] and Peterson et al. showed a 
statistically significant reduction in inpatient falls (0.28 vs 0.64 falls per 100 patient-days; p = 0.001) 
[15]. However, there was no statistically significant difference in the remaining fifteen clinical 
outcomes identified, such as hospital length of stay, readmission rates, or mortality rates (see 
Supplementary Data).  
 
Discussion 
This systematic review and meta-analysis shows that computerised interventions can reduce PIP in 
hospitalised older adults. Although seven of the eight included studies showed a statistically 
significant reduction in PIMs ordered or the proportion of patients prescribed PIMs, it is important 
to note that all of these were single-centre studies. Furthermore, all the included studies in this 
review were conducted in the United States, except for one study conducted in Italy [10], and 
therefore this may impact on the generalisability of the review findings for other countries.  
The acceptance rates of the computer-generated recommendations varied highly across the studies 
that measured this outcome (Table 2). These findings suggest that interventions that target a 
smaller number of PIP instances may have greater recommendation acceptance rates than those 
targeting a wider range of PIP instances. One reason for this may be that prescribers could become 
overwhelmed by the complexity of information provided in broader interventions [19]. It is 
interesting to note that Agostini et al. achieved a 95% success rate in switching to a safer alternative 
to a PIM, whereas only 4/53 (7.5%) recommendations for alternatives were accepted in Griffey et al. 
[13, 18]. Thus, providing a recommendation for an alternative doesn’t necessarily mean that 
prescribers will accept this and discontinue the PIM in question. Further qualitative research is 
required to identify factors affecting implementation of computer-generated recommendations of 
this kind.  
Autonomy is very important when encountering computerised interventions such as these - 
prescribers should be capable of bypassing recommendations where clinically appropriate [18]. 
While overrides are often justified, they can be associated with serious adverse events (or even 
death) if clinically significant information is unintentionally ignored [20]. A common reason for 
overrides may be due to alert fatigue, whereby prescribers may pay less attention if they are 
encountering repeated or inappropriate alerts, or are being inundated by a large quantity of alerts 
[16, 20]. Customisation of alerts for individual institutions may improve their specificity, and 
potentially reduce the occurrence of this phenomenon [21].  
The results of this systematic review are in keeping with that of previous reviews, which have shown 
that computerised interventions may be effective in improving the appropriateness of prescribing in 
older adults. One review assessed the use of electronic prescribing and other forms of technology in 
reducing PIP and polypharmacy in older adults [22], and an older review evaluated computer 
decision support to improve medication prescribing in older adults [23]; however, both studies 
broadly looked at interventions across different healthcare settings. This is the first systematic 
review to focus specifically on computerised interventions which aimed to reduce PIP for older 
adults in the hospital setting.  
It should be noted that only two of the included studies in this review were RCTs, which are 
considered the most robust way of identifying if a cause-effect relationship exists between an 
intervention and outcome [24]. The studies included in the meta-analysis were at a low risk of bias; 
however, the pooled estimate of effects may have been biased as incomplete reporting in some 
papers meant that these were the only studies which allowed comparison of one of the primary 
outcomes (data retrieval bias) [25]. Even though the other studies that assessed this outcome 
showed a statistically significant reduction in the proportion of patients prescribed PIMs, the pooled 
estimate may not accurately represent the true effect that these computerised interventions can 
have on reducing PIP in hospitalised older adults, especially when you consider that the meta-
analysis contained studies that were not RCTs. Despite these limitations, this review is valuable for 
healthcare professionals as it shows that computerised interventions can be implemented in 
hospital settings to reduce instances of PIP for older patients.  
This systematic review aimed to identify computerised interventions targeting PIMs and potential 
prescribing omissions (PPOs). However, the included studies in this review only targeted PIMs, and 
did not identify medication underuse, i.e. PPOs which older patients may benefit from. Despite our 
comprehensive search strategy, it is still possible that all relevant papers may not have been 
identified. A systematic review by Meid et al. recommended that future interventions targeting PIP 
should utilise explicit criteria, such as Screening Tool to Alert doctors to Right Treatment (START), 
alone or in combination with implicit reasoning, to screen for medication underuse in older people 
[26]. Thus, perhaps future computerised interventions should strive to target PPOs, and not just 
PIMs. The SENATOR (https://www.senator-project.eu/) and OPERAM (http://operam-
2020.eu/index.php?id=1488) projects are ongoing multi-centre RCTs taking place in sites across 
Europe, which have computerised the Screening Tool of Older Persons' Prescriptions (STOPP) and 
START criteria as part of their intervention [27]. These trials aim to reduce PIMs and PPOs, prevent 
in-hospital ADRs, and reduce medication-related hospital admissions. 
With the increasing prevalence of electronic prescribing and CPOE worldwide, it should be noted 
that implementing these systems does not always result in positive patient outcomes [28]. Hospital 
managers and other key stakeholders will have to devise strategies to allow for successful 
integration with clinical workflows and with other technologies already in place. All but one of the 
interventions in this review were conducted at the point of prescribing, which may be a key feature 
for designing future studies. The advantage of this is that prescribers are prompted in real-time to 
address medication appropriateness issues to reduce the risk of ADE at the earliest possible point.  
Hospital managers will also have important roles in assigning funding to these computerised 
systems. It has been demonstrated that the extra costs associated with the implementation of CPOE 
with a CDSS are acceptable in the prevention of medication errors and preventable ADEs [29]. 
Further research should aim to identify how best to integrate these new computerised systems into 
routine clinical practice, and to identify methods to increase the acceptance of computer-generated 
recommendations, where appropriate.   
 
Conclusions 
Overall, our findings demonstrate that computerised interventions can be effective in reducing PIP in 
hospitalised older adults.  Larger scale multi-centre RCTs, at national and international levels, will be 
required to further demonstrate the benefit of these interventions across different institutions, 
ideally showing both cost-effectiveness data and clinically significant improvements in patient 
outcomes. 
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PubMed Search Strategy 
 
Inappropriate prescribing OR potentially inappropriate prescribing OR inappropriate prescription* 
OR overprescribing OR underprescribing OR inappropriate polypharmacy OR inappropriate 
medicine* OR inappropriate medication* OR inappropriate drug* OR optimize prescribing OR 
improve appropriateness of prescribing 
AND 
aged OR elder* OR geriatric OR older person* OR older patient* OR older adult* 
AND 
Computer* OR software OR software intervention OR clinical decision support OR CDSS OR CDS  
 
Note: For each of the remaining databases, the search strategy was modified to suit their specific 
















Agostini et al. 










C: 12,356  
I: 12,153          
Total: 
24,509 
The sedative hypnotics diazepam and 
diphenhydramine. 
Patients aged ≥65 years 
admitted to the adult 
inpatient service.    
Physician Computerised reminder in a CPOE system aiming to 
minimise use of diphenhydramine and diazepam, and 
directing physicians to either a nonpharmacological 
sleep protocol or to an alternative medication, such as 
trazodone or lorazepam.  
Boustani et al. 
2012 (USA) [12] 
RCT 21 months C: 225 
I: 199 
Total: 424  
18 medications with moderate to 
severe centrally acting 
anticholinergic properties, selected 
by an interdisciplinary team (which 
included a geriatrician, a geriatric 
nurse practitioner, a pharmacist, a 
social worker, a physical therapist, an 




≥65 years hospitalised on a 
medical ward, with 
cognitive impairment at the 
time of hospital admission. 
Patients excluded if they 
had previously been 
enrolled in the study, were 
aphasic, or unresponsive at 
the time of screening. 
 
Physician If a physician ordered any one of 18 inappropriate 
anticholinergic medications in a CPOE system, a CDSS 
interruptive alert recommended to discontinue the 
medicine, dose modification, or suggested an 
alternative. 
 
Ghibelli et al. 








Total: 134  
PIMs according to the 2003 Beers 
criteria, as these were the explicit 
criteria in INTERcheck®. 
Inpatients ≥65 years – only 
exclusion criteria were 
severe malignancy (life 
expectancy less than 6 
months) or terminal illness. 
Physician The physician utilised a computerised prescription 
support system (INTERcheck®) to identify PIMs and 
potential drug-drug interactions, as well as aiming to 
reduce anticholinergic load and adjust doses in 
patients with renal impairment. 
 
Griffey et al. 




OFF, ON, OFF, 
ON. First two 
blocks were 6 
weeks long 
and last two 
blocks were 7 
weeks long.  
C: 668 
I: 739  
Total 1,407 
Benzodiazepines, NSAIDs, opiates, 
sedative-hypnotics. These were 
selected by an expert panel including 
a geriatrician, a general psychiatrist, 
a pharmacist, two general internists, 
and an anaesthesiologist specialising 
in pain management, as had 
previously been done in Peterson et 
al [18]. 
All persons aged ≥65 years 
who had an order for a 
medication in one of the 
targeted drug classes 
during the study period. 
The study excluded patient 
orders in which qualifying 
medication orders were 
subsequently cancelled and 





Physician When one of the study medications was ordered in a 
CPOE system for patients ≥65 years, a clinical decision 
support tool modified one or more of the following 
parameters: medication selection, default dosage, or 
default frequency. The physician could then choose to 
accept or override the recommendation. The tool was 
alternated ‘OFF’ and ‘ON’ in consecutive blocks during 
the study period.  
 





Lester et al. 

















and all antipsychotics. 
Patients aged ≥65 years. Prescribers – 
doesn’t 
specify.   
Informational alerts popped up when a PIM was 
ordered in the CPOE system. The physician was 
required to acknowledge the alert, before deciding on 
whether to cancel their order or continue prescribing 
the medication.  
 
Mattison et al. 











A list of Beers 2003 criteria 
medications selected by a geriatrician 
and pharmacist, and then revised by 
the hospital’s Pharmacy and 
Therapeutics Committee. 
 
All hospitalised inpatients 
aged ≥65 years. 
Physicians  The CPOE system alerted prescribers when a PIM was 
ordered by providing a medication-specific warning 
that advised alternative medication or dose reduction.  
 
Peterson et al. 





















72 psychotropic medications  
decided on by a panel of experts, 
including a geriatrician, a geriatric 
psychiatrist, a pharmacist, 2 
internists, and an anaesthesiologist 
specialising in pain management. 
 
All patients ≥65 years 
prescribed one of the 
targeted medication and 
admitted to any of the 
medical, surgical, 
neurology, and gynaecology 
services were evaluated. 
General ward and intensive 
care patients were eligible 
for analysis. Only those 
patients whose admission 
was entirely contained 
within 1 of the 6-week 
study periods were 
included. 
 
Physicians A decision support tool altered the default dose and 
frequency for psychotropic medications for patients 
≥65 years, and suggested an alternative medication 
when prescribers ordered one of 12 psychotropic 
medications known to be poorly tolerated in older 
patients. The support tool was activated for 2 of 4 six-
week study periods in an off-on-off-on pattern. 
 
Terrell et al. 
2009 (USA) [14] 
RCT 30 months C: 1,925       
I: 1,793  
Total: 3,718 
9 high-use and high impact PIMs, 
selected by an expert panel 
consisting of two doctors of 
pharmacy, two physician information 
technology experts, three 
geriatricians, and three emergency 
physicians. 
 
The intervention was aimed 
at emergency department 
physicians. 
I: 32 physicians 
C: 31 physicians 
Physicians Physicians in the intervention group were provided 
decision support when they attempted to prescribe a 
PIM for patients ≥65 years who were being discharged 
from the emergency department. The computerised 
reminder provided recommendations for alternatives 
which the physician could accept or reject.   
 
C: Control group; I: Intervention group; CI: Confidence interval; RCT: Randomised controlled trial; CPOE: Computerised physician order entry; CDSS: Clinical decision support system; 
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Was the knowledge of the 
allocated interventions 











Other risks of 
bias 
Overall risk of 
bias 
Griffey et al. [13] 
 
        
Peterson et al. [15] 
 
        
Table 4: Risk of bias assessments. Review authors’ judgements are categorised as ‘Low Risk’ of bias (+), ‘High Risk’ of bias (-) or ‘Unclear Risk’ of bias (?). 
* RCT: Randomised controlled trial 
 
Author Description of Clinical Outcomes 
 
Boustani 
et al. [12] 
 
All clinical outcomes with no statistically significant difference (0/9). 
 
No statistically significant effects on health outcomes including:  
• the mean days of hospital stay (intervention: 7.7 days vs usual care: 6.8, p = 0.12),  
• 30-day mortality rate (intervention: 6% vs usual care: 5.8%, p = 0.69),  
• home discharge (intervention: 43.2% vs usual care: 36.9%, p = 0.13),  
• 30-day readmission rates (intervention: 18.6% vs usual care: 16.4%, p = 0.53),  
• hospital-acquired complications (intervention: 47.2% vs usual care: 44.9%, p = 0.94).  
 
The hospital-acquired complications included:  
• incidence of delirium (intervention: 33.7% vs usual care: 31.1%, p = 0.78),  
• the presence of ICD-9 codes of pressure ulcer at discharge (intervention: 12.1% vs usual 
care: 11.1%, p = 0.77),  
• the presence of ICD-9 code for fall or injury at discharge (intervention: 4.5% vs usual 
care: 4.9%, p = 0.88),  
• orders for physical restraints or patients observed to be physically restrained 
(intervention: 11.1% vs usual care: 7.6%, p = 0.54). 
 
Griffey     
et al. [13] 
One clinical outcome with statistically significant difference* (1/5). 
 
No significant differences were observed in: admission rate, reversal drug administration,  
number of 10-fold orders, or emergency department length of stay. 
 
*ADEs: There were 39 ADEs identified, distributed as 8/237 patients (3%; 95% CI 1% to 6%) 
during ON periods and 31/436 patients (7%; 95% CI 5% to 9%) during OFF periods (p = 0.02). 
 
Peterson 
et al. [15] 
One clinical outcome with statistically significant difference† (1/3). 
 
No difference between control and intervention for length of stay or altered mental status. 
 
†The rate of falls continued to be significantly less (0.28 vs 0.64 falls per 100 patient-days;      







Table 5: Studies which assessed clinical outcomes. 
ICD: International Classification of Diseases; ADE: adverse drug event; CI: Confidence Interval. 
 
 
 
